1-2 of 2
Dolores Mejia, MD
Close
Sort by
Journal Articles

Safety of Intrathecal Rituximab as Prophylaxis or Treatment in CD20+ Acute Lymphoblastic and Aggressive Lymphoma: Report from a Mexican Pilot Study.

Luis Villela, MD, Rocio Caballero-Caballero, MD, Josefa Piedras-Ross, Hetor Garcia-Herrera, MD, Dolores Mejia, MD, Jose R. Borbolla Escoboza, MD
Journal: Blood
Blood (2006) 108 (11): 4713.
https://doi.org/10.1182/blood.V108.11.4713.4713
Published: 2006
Journal Articles

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Jose R. Borbolla Escoboza, MD, Marcos E. Garza-Madrid, MD, Martha Alvarado, MD, Enrique Baez, MD, Manuel A. Lopez-Hernández, MD, Jose E. DeDiego, MD, Severiano Baltazar, MD, Maria I. Leon-Castanon, MSC, Julio C. Rojas-Martinez, MD, Cecilia Ramirez-Assad, MD, Elvira Trueba, MD, Gerardo Villarreal, MD, Luis M. Villela, MD, Jorge Cruz-Rico, MD, Monica Tejeda, MD, Jorge Duque, MD, Mauricio C. Gonzalez-Avante, MD, Teresa Pompa, MD, Irene Anaya, MD, Leonel Ochoa, MD, Guadalupe Gonzalez, MD, Maria de la Luz Mendizabal, MD, Rosa M. Jimenez, MD, Roberto Hernandez, MD, Dolores Mejia, MD, Eduardo Romero, MD, Carlos Gil-Rondero, MD, Jorge L. Juarez, MD, Rosa E. De Leon, MD, Yara E. Tovar, MD, Jason A. Penniecook, MD
Journal: Blood
Blood (2004) 104 (11): 4312.
https://doi.org/10.1182/blood.V104.11.4312.4312
Published: 2004